Diazyme's Apo A-I Assay kit has a linear range of 1.44 - 250 mg/dL and good correlation with an existing FDA approved product with r2 values >0.98. The Diazyme
Apo A-I Assay is not interfered by the following substances at the indicated concentrations: triglycerides at 1000 mg/dL, ascorbic acid at 10 μM, bilirubin at
40 mg/dL, bilirubin conjugate at 40 mg/dL, and hemoglobin at 1000 mg/dL.
This method is based on the reaction of a sample containing human apo A-I and a specific
antiserum to form an insoluble complex which can be measured turbidimetrically at 340 nm. By
constructing a standard curve from the absorbance of standards the concentration of apo A-I
in the sample can be determined.
The Diazyme Apolipoprotein A-I Assay is intended for the in vitro quantitative determination of Apolipoprotein A-I (Apo A-I) in serum. It can be used as an aid for
assessing the risk of coronary artery disease. For in vitro diagnostic use.
|Kit (1120 Tests)
||R1: 4 x 70 mL
R2: 2 x 50 mL
||1 x 1 mL
||3 x 3 mL